Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Benekli

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|March 3, 2010
Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomasSuleyman Alici, Ugur Coskun, Necati Alkis, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancerEmel Yaman, Aytug Uner, Ozlem Er, et al.
Onkologie|June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatmentEmel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)Oktay Bozkurt, Halit Karaca, Aydin Ciltas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences, Bala Basak Oven Ustaalioglu, Mahmut Gumus, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimenMehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, et al.
Medical Oncology (Northwood, London, England)|December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinomaBanu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2013
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinomaSuleyman Alici, Suleyman Buyukberber, Necati Alkis, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancerAziz Karaoglu, Ulku Yalcintas Arslan, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Asian Pacific Journal of Cancer Prevention : APJCP|March 3, 2010
Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomasSuleyman Alici, Ugur Coskun, Necati Alkis, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancerEmel Yaman, Aytug Uner, Ozlem Er, et al.
Onkologie|June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatmentEmel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO)Oktay Bozkurt, Halit Karaca, Aydin Ciltas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences, Bala Basak Oven Ustaalioglu, Mahmut Gumus, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimenMehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, et al.
Medical Oncology (Northwood, London, England)|December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinomaBanu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2013
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinomaSuleyman Alici, Suleyman Buyukberber, Necati Alkis, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancerAziz Karaoglu, Ulku Yalcintas Arslan, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Pageof 13